Effector Therapeutics Price History

EFTRDelisted Stock  USD 0.13  0.03  30.00%   
If you're considering investing in Effector Stock, it is important to understand the factors that can impact its price. As of today, the current price of Effector Therapeutics stands at 0.13, as last reported on the 20th of December, with the highest price reaching 0.17 and the lowest price hitting 0.07 during the day. We have found twenty-three technical indicators for Effector Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Effector Therapeutics' Variance of 230.42, mean deviation of 7.57, and Standard Deviation of 15.18 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Effector Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
EFTR
Based on monthly moving average Effector Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Effector Therapeutics by adding Effector Therapeutics to a well-diversified portfolio.

Effector Therapeutics Stock Price History Chart

There are several ways to analyze Effector Stock price data. The simplest method is using a basic Effector candlestick price chart, which shows Effector Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Effector Stock Price History Data

The price series of Effector Therapeutics for the period between Sat, Sep 21, 2024 and Fri, Dec 20, 2024 has a statistical range of 16.34 with a coefficient of variation of 134.12. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.27. The median price for the last 90 days is 1.82. The company completed 1:25 stock split on 12th of January 2024.
OpenHighLowCloseVolume
12/20/2024
 0.10  0.17  0.07  0.13 
07/03/2024 0.10  0.17  0.07  0.13  993,887 
07/02/2024 0.23  0.24  0.17  0.18  1,631,337 
07/01/2024 0.27  0.28  0.24  0.27  1,124,669 
06/28/2024 0.29  0.30  0.28  0.29  1,306,943 
06/27/2024 0.28  0.33  0.27  0.31  2,462,781 
06/26/2024 0.31  0.31  0.26  0.27  4,886,736 
06/25/2024 0.29  0.38  0.28  0.28  12,648,230 
06/24/2024 0.29  0.35  0.25  0.28  5,914,730 
06/21/2024 1.19  1.32  1.14  1.17  175,418 
06/20/2024 1.20  1.28  1.17  1.17  110,218 
06/18/2024 1.22  1.26  1.16  1.16  72,239 
06/17/2024 1.25  1.27  1.21  1.24  52,687 
06/14/2024 1.37  1.37  1.25  1.25  54,366 
06/13/2024 1.34  1.47  1.32  1.37  89,073 
06/12/2024 1.29  1.40  1.29  1.35  67,548 
06/11/2024 1.26  1.38  1.23  1.31  62,645 
06/10/2024 1.30  1.35  1.19  1.30  119,153 
06/07/2024 1.37  1.43  1.31  1.31  87,459 
06/06/2024 1.46  1.48  1.38  1.38  61,052 
06/05/2024 1.44  1.55  1.39  1.48  61,579 
06/04/2024 1.56  1.60  1.38  1.42  163,489 
06/03/2024 1.64  1.66  1.50  1.56  244,190 
05/31/2024 1.71  1.73  1.53  1.60  203,497 
05/30/2024 1.65  1.73  1.65  1.70  40,296 
05/29/2024 1.74  1.74  1.65  1.66  74,695 
05/28/2024 1.67  1.77  1.67  1.75  66,187 
05/24/2024 1.86  1.91  1.76  1.78  52,455 
05/23/2024 1.80  1.86  1.73  1.82  83,519 
05/22/2024 1.79  1.84  1.65  1.76  69,456 
05/21/2024 1.83  1.88  1.72  1.79  95,000 
05/20/2024 1.93  1.99  1.86  1.87  119,527 
05/17/2024 1.98  2.00  1.92  1.94  61,594 
05/16/2024 2.02  2.02  1.96  1.98  56,928 
05/15/2024 1.98  2.05  1.94  1.98  111,368 
05/14/2024 2.01  2.06  1.95  2.00  133,625 
05/13/2024 2.06  2.06  1.98  2.00  108,205 
05/10/2024 2.09  2.13  2.00  2.03  85,411 
05/09/2024 2.08  2.14  1.98  2.14  120,545 
05/08/2024 2.09  2.13  1.96  2.08  118,263 
05/07/2024 2.12  2.23  2.03  2.05  85,724 
05/06/2024 2.19  2.26  2.10  2.13  80,322 
05/03/2024 2.12  2.29  2.12  2.20  144,765 
05/02/2024 2.26  2.26  2.08  2.16  108,688 
05/01/2024 2.25  2.34  2.17  2.20  63,095 
04/30/2024 2.07  2.27  2.02  2.25  188,873 
04/29/2024 1.94  2.13  1.92  2.07  227,837 
04/26/2024 1.81  1.96  1.81  1.89  162,186 
04/25/2024 1.86  1.87  1.75  1.81  180,978 
04/24/2024 1.90  1.94  1.80  1.85  108,175 
04/23/2024 1.80  2.00  1.78  1.94  149,714 
04/22/2024 1.67  1.87  1.63  1.78  177,232 
04/19/2024 1.80  1.80  1.60  1.70  197,098 
04/18/2024 1.91  1.91  1.75  1.78  146,195 
04/17/2024 2.01  2.05  1.81  1.89  136,014 
04/16/2024 1.89  2.03  1.89  1.99  234,633 
04/15/2024 2.12  2.12  1.83  1.93  415,595 
04/12/2024 2.27  2.27  2.03  2.08  294,306 
04/11/2024 2.34  2.37  2.17  2.24  347,235 
04/10/2024 2.31  2.39  2.24  2.36  255,844 
04/09/2024 2.17  2.46  2.14  2.31  818,706 

About Effector Therapeutics Stock history

Effector Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Effector is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Effector Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Effector Therapeutics stock prices may prove useful in developing a viable investing in Effector Therapeutics
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California. Effector Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.

Effector Therapeutics Stock Technical Analysis

Effector Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Effector Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Effector Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Effector Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Effector Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Effector Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Effector to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Effector Stock

If you are still planning to invest in Effector Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Effector Therapeutics' history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories